Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Breast Neoplasms 2Urologic Diseases 1Taste Disorders 1Renal Insufficiency 1Recurrence 1Malnutrition 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Kidney Neoplasms 1Kidney Diseases 1Intracranial Germ Cell Tumors 1Hypothermia 1Carcinoma, Renal Cell 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 387Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Ice × Clear all
NCT04822597 2023-08-03

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

University of Wisconsin, Madison

Phase 3 Completed
167 enrolled 21 charts
Breast

Breast Neoplasms

NCT00020722 2016-02-17

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Terminated
7 enrolled 3 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡